JMP Securities upgraded Sabra Health Care (SBRA) to Outperform from Market Perform with a $20 price target The firm expects “multiple tailwinds to result in outsized returns” for the stock.

I created Within This Party as a graduation project in 2022. The world was not much better back then, than it is today. Although perhaps on the surface, it was brighter. But there was darkness in ...

But even with clearer guidance on this issue, it will likely be difficult for most consumers to interpret the disclosures on the new labels. Heavy metals are not unique to processed baby food.

On Dec. 5, Mizuho analyst Vikram Malhotra downgraded the rating for Sabra Health Care REIT from Outperform to Neutral and maintained the price target of $20. On Oct. 31, Sabra Health Care REIT ...

Fintel reports that on January 7, 2025, JMP Securities upgraded their outlook for Sabra Health Care REIT (NasdaqGS:SBRA) from Market Perform to Market Outperform. As of December 23, 2024 ...

Much of America’s hummus explosion can be traced to one company, Sabra, which was in the news last week after an outbreak of listeria in Sabra hummus prompted a major recall. Its rival Tribe has ...